T1	intervention 0 37	Palbociclib Combined with Fulvestrant
T4	total-participants 573 576	521
T5	intervention-participants 599 602	347
T6	control-participants 603 606	174
T7	control 715 722	placebo
T8	outcome 1101 1111	Median PFS
T2	iv-bin-abs 1160 1162	72
T9	cv-bin-abs 1188 1190	36
T10	iv-cont-median 1196 1199	9.5
T11	cv-cont-median 1207 1217	5.6 months
T12	outcome 1787 1801	well-tolerated
T13	outcome 1773 1782	effective
T3	outcome 1385 1419	Any-grade and grade â‰¤3 neutropenia
T14	outcome 1421 1431	leukopenia
T15	outcome 1437 1447	infections
T16	outcome 1566 1588	Hormone concentrations
T17	outcome 1477 1491	adverse events
